FIELD: organic chemistry, medicine, pharmacology.
SUBSTANCE: invention relates to a combination used in prophylaxis and/or treatment of thromboembolic diseases. Combination comprises N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-5-chloro-2-thiophene carboxamide of the formula (I): its pharmaceutically acceptable salts, hydrates or their mixtures and platelet aggregation inhibitor taken in subtherapeutic effective doses. Also, invention relates to a method for preparing this combination and a drug based on thereof. Proposed combination possesses the enhanced effectiveness.
EFFECT: improved and valuable medicinal properties of combination.
4 cl, 2 tbl, 176 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED OXAZOLIDINONES, METHODS FOR THEIR PREPARING, MEDICINAL AGENT BASED ON THEREOF AND USING SUBSTITUTED OXAZOLIDINONES | 2000 |
|
RU2297415C2 |
AMINOACYL DERIVATIVE PRODRUGS AND PREPARATIONS FOR TREATING THROMBOEMBOLIC DISEASES | 2007 |
|
RU2435768C2 |
DERIVATIVES OF TAXANE | 1993 |
|
RU2188198C2 |
SPLICEOSTATIN ANALOGS | 2013 |
|
RU2618523C2 |
DERIVATIVES OF PYRIMIDINONE AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS, WHICH HAS PROPERTIES OF HUMAN NEUTROPHIL ELASTASE INHIBITOR | 2003 |
|
RU2376295C9 |
OXAZOLIDINONE DERIVATIVES, METHOD FOR PREPARING THEREOF (VERSIONS) AND BASED PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2417223C2 |
PYRAZOLE DERIVATIVES AND THEIR USE | 2020 |
|
RU2805207C1 |
CETP INHIBITORS | 2006 |
|
RU2513107C2 |
AMINOACYL DERIVATIVES AS PRODRUGS AND PREPARATIONS FOR TREATING THROMBOEMBOLIC DISEASES | 2007 |
|
RU2456283C9 |
METHODS FOR OBTAINING BENZODIAZEPINE DERIVATIVES | 2018 |
|
RU2794124C2 |
Authors
Dates
2008-04-10—Published
2002-06-07—Filed